| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |